Virtual Medicinal Product (VMP)
-
Reslizumab 100mg/10ml solution for infusion vials
Name Details
Current Name
Reslizumab 100mg/10ml solution for infusion vials
|
Start Date
18-01-2017
|
End Date
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 10.0
- UDFS UOM
- ml
- Unit Dose UOM
- vial
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Intravenous
- Form
- Solution for infusion
- Ontology Form/Route
- solutioninfusion.intravenous
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
R03DX08
BNF |
Current BNF
03040200
|
Start Date
04-04-2022
|
End Date
|
Previous BNF
03040200
|
Start Date
28-06-2017
|
End Date
03-04-2022
|
SNOMED Codes
Code
|
Start Date
|
End Date
|
33999611000001101 |
18-01-2017 |
|
VMP Ingredients
VMP ingredients table
Reslizumab |
Based on Ingredient Substance |
|
10 mg |
1 ml |
Name
Reslizumab
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
10.0
Strength and UOM (Dmr)
1.0
Parent Products
-
VTM
Reslizumab
-
VMP
(Current) Reslizumab 100mg/10ml solution for i...
Virtual Medicinal Product Pack (VMPP) Information